tremelimumab,durvalumab
astrazeneca
['himalaya', 'bcsm', 'gi ']
#asco22 keep refreshing your feeds. himalaya trial now published online 2022 progress for pts with gi malignancies. stride regimen
this idea of just 1 dose of ctla4 is very intriguing! #hpbcsm likely soc 
Oncologist | Researcher | ColorectalCancer #CRCSM???????@MayoClinic @PittTweet Alum; ??#ctDNA #LiquidBiopsies??#PrecisionOncology ViewsMy Own. COI @ASCO #ASCO22